Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 16:00 PM 2012  
PAYX MAN JOBS KFY DHX CODI 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for NVS and SNY ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 Novartis AG  and   SanofiAventis
Check Correlation Matrix  
Daily Returns (%)
SNY  NVS  
Timeline
Considering 30-days investment horizon, Novartis AG is expected to generate 0.46 times more return on investment than SanofiAventis. However, Novartis AG is 2.16 times less risky than SanofiAventis. It trades about -0.43 of its potential returns per unit of risk. SanofiAventis is currently generating about -0.31 per unit of risk. If you would invest 5,502 in Novartis AG on April 26, 2012 and sell it today you would lose (306.00) from holding Novartis AG or give up 5.56% of portfolio value over 30 days.

Diversification

Modest diversification
Overlapping area represents amount of risk that can be diversified away by holding Novartis AG and SanofiAventis in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

0.24
 Parameters
Time Period1 Month [change]
DirectionPositive SNY Moved Up vs NVS
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between NVS and SNY with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between NVS and SNY to your reader
 
Get social with Correlation between NVS and SNY
 Share Correlation between NVS and SNY 
Share Share Correlation between NVS and SNY
    
    
 
       
Predicted Return Density
Expected Daily Returns   
SNY  NVS  

Novartis AG

 
    
    
Novartis
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Novartis AG has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Johnson & Johnson vs. Novartis AG
Pfizer Inc. vs. Novartis AG
Merck & Inc. vs. Novartis AG
GlaxoSmithKline plc vs. Novartis AG
Abbott Laboratories vs. Novartis AG
SanofiAventis vs. Novartis AG
  

SanofiAventis

 
    
    
SanofiAventis
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days SanofiAventis has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Johnson & Johnson vs. SanofiAventis
Pfizer Inc. vs. SanofiAventis
Novartis AG vs. SanofiAventis
Merck & Inc. vs. SanofiAventis
GlaxoSmithKline plc vs. SanofiAventis
Abbott Laboratories vs. SanofiAventis
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting